Acute Basilar Artery Occlusion

Does Recanalization Improve Clinical Outcome? A Critically Appraised Topic

Chia Chun Chiang, Oana M. Dumitrascu, Dean Marko Wingerchuk, Cumara B. O'Carroll

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Acute basilar artery occlusion (BAO) is a devastating, life-threatening condition that accounts for approximately 1% of all strokes. Currently, there is no consensus on the best treatment strategy for patients with BAO. Whereas endovascular reperfusion therapy is proven to improve outcomes in anterior circulation stroke, its benefit in acute BAO has not been confirmed in randomized controlled trials. Objective: To critically assess the current evidence regarding recanalization in acute BAO, and to discuss the outcomes of different treatment strategies in the management of acute BAO. Materials and Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, and content experts in the field of vascular and hospital neurology. Results: A recent meta-analysis was selected for critical appraisal to assess the recanalization hypothesis in acute BAO. The authors performed a systematic literature search through August 2013 and pooled in the analysis of 45 studies and 2056 patients. The overall recanalization rate was 75% in this meta-analysis. The authors concluded that recanalization was associated with a 1.5-fold reduction in the risk of death or dependency, and a 2-fold reduction in the risk of mortality. Subgroup analysis comparing different modes of intervention revealed data that favor endovascular intervention over intravenous thrombolysis (IVT). However, the authors were not able to obtain a statistically valid direct comparison of the 2 therapies as their meta-analysis included observational studies. Subgroup analysis on the treatment window revealed that onset-to-treatment time of <12 hours was associated with a higher recanalization rate (81%) and a lower intracranial hemorrhage rate (10%) compared with onset-to-treatment time >12 hours. Conclusions: IVT is the standard of care for BAO patients presenting within 4.5 hours of symptom onset, whereas recanalization is associated with better outcomes regardless of how recanalization is achieved. Randomized controlled trials comparing IVT plus endovascular treatment versus IVT in the treatment of acute BAO are needed to provide evidence-based management guidance.

Original languageEnglish (US)
Pages (from-to)71-74
Number of pages4
JournalNeurologist
Volume23
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Basilar Artery
Meta-Analysis
Risk Reduction Behavior
Therapeutics
Randomized Controlled Trials
Stroke
Mobile Health Units
Standard of Care
Neurology
Consultants
Reperfusion
Observational Studies
Blood Vessels
Consensus
Mortality

Keywords

  • basilar artery occlusion
  • endovascular treatment
  • intravenous thrombolysis
  • recanalization
  • revascularization

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Acute Basilar Artery Occlusion : Does Recanalization Improve Clinical Outcome? A Critically Appraised Topic. / Chiang, Chia Chun; Dumitrascu, Oana M.; Wingerchuk, Dean Marko; O'Carroll, Cumara B.

In: Neurologist, Vol. 23, No. 2, 01.01.2018, p. 71-74.

Research output: Contribution to journalArticle

Chiang, Chia Chun ; Dumitrascu, Oana M. ; Wingerchuk, Dean Marko ; O'Carroll, Cumara B. / Acute Basilar Artery Occlusion : Does Recanalization Improve Clinical Outcome? A Critically Appraised Topic. In: Neurologist. 2018 ; Vol. 23, No. 2. pp. 71-74.
@article{916f1df1a51f4e3a977a8b7becb5aa4b,
title = "Acute Basilar Artery Occlusion: Does Recanalization Improve Clinical Outcome? A Critically Appraised Topic",
abstract = "Background: Acute basilar artery occlusion (BAO) is a devastating, life-threatening condition that accounts for approximately 1{\%} of all strokes. Currently, there is no consensus on the best treatment strategy for patients with BAO. Whereas endovascular reperfusion therapy is proven to improve outcomes in anterior circulation stroke, its benefit in acute BAO has not been confirmed in randomized controlled trials. Objective: To critically assess the current evidence regarding recanalization in acute BAO, and to discuss the outcomes of different treatment strategies in the management of acute BAO. Materials and Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, and content experts in the field of vascular and hospital neurology. Results: A recent meta-analysis was selected for critical appraisal to assess the recanalization hypothesis in acute BAO. The authors performed a systematic literature search through August 2013 and pooled in the analysis of 45 studies and 2056 patients. The overall recanalization rate was 75{\%} in this meta-analysis. The authors concluded that recanalization was associated with a 1.5-fold reduction in the risk of death or dependency, and a 2-fold reduction in the risk of mortality. Subgroup analysis comparing different modes of intervention revealed data that favor endovascular intervention over intravenous thrombolysis (IVT). However, the authors were not able to obtain a statistically valid direct comparison of the 2 therapies as their meta-analysis included observational studies. Subgroup analysis on the treatment window revealed that onset-to-treatment time of <12 hours was associated with a higher recanalization rate (81{\%}) and a lower intracranial hemorrhage rate (10{\%}) compared with onset-to-treatment time >12 hours. Conclusions: IVT is the standard of care for BAO patients presenting within 4.5 hours of symptom onset, whereas recanalization is associated with better outcomes regardless of how recanalization is achieved. Randomized controlled trials comparing IVT plus endovascular treatment versus IVT in the treatment of acute BAO are needed to provide evidence-based management guidance.",
keywords = "basilar artery occlusion, endovascular treatment, intravenous thrombolysis, recanalization, revascularization",
author = "Chiang, {Chia Chun} and Dumitrascu, {Oana M.} and Wingerchuk, {Dean Marko} and O'Carroll, {Cumara B.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/NRL.0000000000000156",
language = "English (US)",
volume = "23",
pages = "71--74",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Acute Basilar Artery Occlusion

T2 - Does Recanalization Improve Clinical Outcome? A Critically Appraised Topic

AU - Chiang, Chia Chun

AU - Dumitrascu, Oana M.

AU - Wingerchuk, Dean Marko

AU - O'Carroll, Cumara B.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Acute basilar artery occlusion (BAO) is a devastating, life-threatening condition that accounts for approximately 1% of all strokes. Currently, there is no consensus on the best treatment strategy for patients with BAO. Whereas endovascular reperfusion therapy is proven to improve outcomes in anterior circulation stroke, its benefit in acute BAO has not been confirmed in randomized controlled trials. Objective: To critically assess the current evidence regarding recanalization in acute BAO, and to discuss the outcomes of different treatment strategies in the management of acute BAO. Materials and Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, and content experts in the field of vascular and hospital neurology. Results: A recent meta-analysis was selected for critical appraisal to assess the recanalization hypothesis in acute BAO. The authors performed a systematic literature search through August 2013 and pooled in the analysis of 45 studies and 2056 patients. The overall recanalization rate was 75% in this meta-analysis. The authors concluded that recanalization was associated with a 1.5-fold reduction in the risk of death or dependency, and a 2-fold reduction in the risk of mortality. Subgroup analysis comparing different modes of intervention revealed data that favor endovascular intervention over intravenous thrombolysis (IVT). However, the authors were not able to obtain a statistically valid direct comparison of the 2 therapies as their meta-analysis included observational studies. Subgroup analysis on the treatment window revealed that onset-to-treatment time of <12 hours was associated with a higher recanalization rate (81%) and a lower intracranial hemorrhage rate (10%) compared with onset-to-treatment time >12 hours. Conclusions: IVT is the standard of care for BAO patients presenting within 4.5 hours of symptom onset, whereas recanalization is associated with better outcomes regardless of how recanalization is achieved. Randomized controlled trials comparing IVT plus endovascular treatment versus IVT in the treatment of acute BAO are needed to provide evidence-based management guidance.

AB - Background: Acute basilar artery occlusion (BAO) is a devastating, life-threatening condition that accounts for approximately 1% of all strokes. Currently, there is no consensus on the best treatment strategy for patients with BAO. Whereas endovascular reperfusion therapy is proven to improve outcomes in anterior circulation stroke, its benefit in acute BAO has not been confirmed in randomized controlled trials. Objective: To critically assess the current evidence regarding recanalization in acute BAO, and to discuss the outcomes of different treatment strategies in the management of acute BAO. Materials and Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, and content experts in the field of vascular and hospital neurology. Results: A recent meta-analysis was selected for critical appraisal to assess the recanalization hypothesis in acute BAO. The authors performed a systematic literature search through August 2013 and pooled in the analysis of 45 studies and 2056 patients. The overall recanalization rate was 75% in this meta-analysis. The authors concluded that recanalization was associated with a 1.5-fold reduction in the risk of death or dependency, and a 2-fold reduction in the risk of mortality. Subgroup analysis comparing different modes of intervention revealed data that favor endovascular intervention over intravenous thrombolysis (IVT). However, the authors were not able to obtain a statistically valid direct comparison of the 2 therapies as their meta-analysis included observational studies. Subgroup analysis on the treatment window revealed that onset-to-treatment time of <12 hours was associated with a higher recanalization rate (81%) and a lower intracranial hemorrhage rate (10%) compared with onset-to-treatment time >12 hours. Conclusions: IVT is the standard of care for BAO patients presenting within 4.5 hours of symptom onset, whereas recanalization is associated with better outcomes regardless of how recanalization is achieved. Randomized controlled trials comparing IVT plus endovascular treatment versus IVT in the treatment of acute BAO are needed to provide evidence-based management guidance.

KW - basilar artery occlusion

KW - endovascular treatment

KW - intravenous thrombolysis

KW - recanalization

KW - revascularization

UR - http://www.scopus.com/inward/record.url?scp=85044737569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044737569&partnerID=8YFLogxK

U2 - 10.1097/NRL.0000000000000156

DO - 10.1097/NRL.0000000000000156

M3 - Article

VL - 23

SP - 71

EP - 74

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 2

ER -